The Bear Case for Merck & Co. (MRK)
Merck & Co., Inc. bear case, commissioned by the divergence screener on robust multiples — P/OCF, EV/EBITDA, P/S — versus their own five-year history, as of June 26, 2026.
By TGMCharts Research / 7 min read / Data as of / Updated
Bear-case divergence
Merck & Co., Inc. screened on an expensive-and-slowing divergence: P/OCF is 1.1x its own five-year median while free cash flow has compounded at 15.69%.
The read leans on the robust multiples — P/OCF at the 76th percentile of its range and EV/EBITDA at the 56th percentile — with ROIC of 18.27% as the quality check; the headline P/E of 36.24x is treated as the noisy counterpoint.
What to watch
- Free-cash-flow trajectory against its five-year CAGR of 15.69%.
- ROIC of 18.27% versus the company's cost of capital.
- Whether the robust multiples re-rate while operating margin of 36.17% holds.
Key takeaways
- -Merck & Co., Inc. closed at $129 on June 26, 2026 with a market cap of $317.08B.
- -This is a mixed bear case: across 28 analysts the average price target is $130, 1.35% from the current price, against a buy-leaning Street.
- -P/OCF is 17.78x versus a 15.40x five-year median (1.1x of it), at the 76th percentile of its range.
- -EV/EBITDA is 14.95x (median 14.34x) at the 56th percentile, and P/S is at the 84th percentile of their own five-year ranges.
- -Five-year revenue CAGR is 8.60% and five-year free-cash-flow CAGR is 15.69%.
- -ROIC is 18.27%, operating margin is 36.17%, and the headline P/E is 36.24x.
Divergence snapshot
The robust cash, enterprise, and revenue multiples versus their own five-year history, with the growth and quality support behind them.
Executive Summary
This fundamental evaluation is generated directly from quantitative screening signals. Merck & Co., Inc. has triggered a valuation divergence because several of its core cash flow and enterprise multiples are sitting near the top of their historic ranges, even as trailing twelve-month revenue expansion has moderated to 2.47%. This setup suggests a premium valuation that has outpaced its underlying expansion rate, prompting a rigorous review of whether these multiples can be sustained.
Rather than relying on the headline GAAP earnings multiple, this analysis focuses on cleaner operational metrics. The price-to-operating-cash-flow ratio is currently trading at 1.1x its five-year median, while the enterprise-to-EBITDA multiple is also sitting at 1.0x its historical midpoint. We evaluate whether the company's operational cash generation and efficiency profile support these elevated trading bands.
Supporting exhibit 1
MRK Price Chart
Latest close: $129 as of June 26, 2026.
The close at $129 is the market's current vote, while this note is really about where the company's cash and revenue multiple sit versus their OWN five-year history — a growth-and-quality question, not a share-price one.
Open source chartWhy This Screened
The divergence screener flags companies where multiple valuation metrics have drifted into historically high percentiles simultaneously, indicating a systemic premium rather than a single anomalous ratio. For this business, cash, enterprise value, and top-line multiples are all clustered near five-year highs, signaling a broad-based re-rating that warrants close fundamental inspection.
The alignment of these distinct metrics is significant. Having the price-to-operating-cash-flow multiple at the 76th percentile of its historical range, alongside an EV/EBITDA multiple at the 56th percentile and a price-to-sales ratio at the 84th percentile, provides a highly consistent signal across different levels of the financial statements, reducing the likelihood of accounting-driven distortions.
Each multiple vs its own five-year history
What each valuation multiple reads now, its typical (median) reading over the past five years, and where the latest reading sits in that range. A low percentile means the stock is historically cheap for this company.
| Metric | Now | Five-year median | Where it sits in its five-year range |
|---|---|---|---|
| P/OCF — price to operating cash flow | 17.78x | 15.40x | 76th percentile |
| EV/EBITDA — enterprise value to EBITDA | 14.95x | 14.34x | 56th percentile |
| P/S — price to sales | 4.85x | 4.40x | 84th percentile |
Valuation Versus Its Own History
Focusing on price-to-operating-cash-flow as the primary operational valuation tool reveals a clear historical stretch. The current P/OCF ratio of 17.78x is elevated relative to the five-year median of 15.40x, positioning the stock in its 76th percentile historical percentile. This multiple expansion has occurred while longer-term compounding, represented by a five-year free cash flow CAGR of 15.69%, shows a different trajectory.
Other robust metrics confirm this historical stretch. The enterprise multiple of 14.95x is higher than the five-year median of 14.34x, placing it in the 56th percentile of its range, while the price-to-sales multiple sits in the 84th percentile of its own history. Because the top-line multiple is less sensitive to temporary margin fluctuations, its elevated position suggests that the overall valuation expansion is structural rather than a temporary reflection of lower expenses.
Primary exhibit
MRK price-to-operating-cash-flow Chart
Price-to-operating-cash-flow is the cleanest robust multiple — pure operating cash, before the capex and financing choices that distort earnings — so it leads the valuation read.
P/OCF is 17.78x today versus a 15.40x five-year median — 1.1x of it, the 76th percentile of its range.
P/OCF sits at the 76th percentile of its own five-year range while operating cash flow has kept compounding — the gap between the cash multiple and the cash itself is the heart of the divergence.
Open source chartSupporting exhibit 3
MRK EV/EBITDA Chart
EV/EBITDA brings the capital structure into the multiple, so debt and cash are not ignored the way an equity-only ratio ignores them.
EV/EBITDA is 14.95x today versus a 14.34x five-year median — 1.0x of it, the 56th percentile of its range.
EV/EBITDA at the 56th percentile of its own range confirms the P/OCF read on an enterprise basis, because a richer or cheaper equity multiple can be an artifact of leverage that EV/EBITDA strips out.
Open source chartSupporting exhibit 4
MRK price-to-sales Chart
Price-to-sales is the revenue-anchored multiple, least disturbed by one-time charges that can swing earnings and even EBITDA in a single quarter.
P/S is 1.1x its own five-year median, at the 84th percentile of its range.
P/S at the 84th percentile of its own range matters most beside net margin of 13.62%, because a revenue multiple is only as defensible as the margin the revenue converts into.
Open source chartGrowth And Cash Support
A premium valuation requires sustained operational expansion to remain viable over the long term. The company's five-year revenue CAGR stands at 8.60%, while free cash flow has expanded at a five-year CAGR of 15.69%. A key vulnerability emerges when these long-term compounding rates are compared to the current valuation percentiles.
The relationship between these metrics highlight the core risk. The five-year free cash flow compound growth of 15.69% is being valued at a price-to-operating-cash-flow multiple in the 76th percentile of its historical range, creating a tension between historical cash performance and the valuation premium currently demanded by the market.
Supporting exhibit 5
MRK revenue
Revenue history is the business-expansion evidence the valuation multiple has to be judged against.
Five-year revenue CAGR: 8.60%.
A five-year revenue CAGR of 8.60% is the demand that the multiple is being paid for; the divergence only matters if revenue is still moving while the multiple has re-rated.
Open source chartSupporting exhibit 6
MRK free cash flow
Free cash flow is the cash the business actually throws off, the support behind both the P/OCF read and the quality case.
Five-year free-cash-flow CAGR: 15.69%.
Free-cash-flow growth of 15.69% over five years is the support the cash multiple rests on: a multiple only means what the cash behind it does, so the direction of this line decides whether the read holds.
Open source chartQuality And Margins
The underlying quality of the business is central to evaluating whether a historical premium can be sustained. The company currently generates a return on invested capital of 18.27% alongside an operating margin of 36.17%, which serve as benchmarks for capital efficiency and profitability.
The net margin of 13.62% provides the final link to the top-line valuation. A price-to-sales multiple in the 84th percentile of its historical range is highly sensitive to margin performance, as any contraction in net margin would directly weaken the earnings power supporting that revenue-based premium.
Supporting exhibit 7
MRK ROIC Chart
Return on invested capital is the quality test — whether the company earns more than its cost of capital on the money it puts to work.
Latest ROIC: 18.27%.
ROIC of 18.27% is the quality test behind the multiple: the higher and steadier the return on capital, the more a multiple at this end of its range reflects mispricing rather than a fair re-rating — and the lower it is, the more the multiple has to be earned.
Open source chartBull/Bear Case
The core bear case is built on the divergence between the company's valuation and its operational trends, with key multiples in the upper quartiles of their historical ranges while five-year free cash flow growth is 15.69% and ROIC is 18.27%. The trailing GAAP P/E of 36.24x acts as a noisy counterpoint, as it is often influenced by non-operational accounting items that do not reflect core cash generation.
Conversely, a bull case would argue that the current premium is justified by structural improvements in business quality. If the company's return on capital and cash flow generation can accelerate, the elevated multiples could be sustained without a downward adjustment.
This analysis presents a different perspective than the broader consensus. Among the 28 analysts tracking the stock, the average price target is $130, representing an upside of 1.35% from current levels, indicating that the market consensus remains constructive despite the historically high valuation multiples.
Bull and bear case
Divergence support
- P/OCF at the 76th percentile of its own range while free cash flow compounds at 15.69% is the core of the case.
- ROIC of 18.27% and operating margin of 36.17% say the business quality supports a re-rating, not just a low multiple.
Divergence risk
- Multiples can stay compressed if growth fades, so the case is conditional on free-cash-flow CAGR of 15.69% holding.
- The headline P/E of 36.24x is the counterpoint — where it disagrees with the cash multiples, reported earnings may carry one-time items worth checking.
Counterpoint exhibit 8
MRK P/E ratio Chart
The headline P/E is the counterpoint, not the anchor — GAAP earnings absorb impairments, tax items, and non-cash charges that the cash and revenue multiples sidestep.
Trailing P/E: 36.24x.
A trailing P/E of 36.24x is the noisiest read here; when it disagrees with the cash and EV multiples, the gap usually says more about one-time items in reported earnings than about the valuation, which is why this note leans on P/OCF and EV/EBITDA instead.
Open source chartWhat Would Change The View
This thesis would be invalidated if cash flow generation accelerates significantly beyond the five-year free cash flow CAGR of 15.69%. A sustained increase in operational cash flow would naturally lower the P/OCF multiple without requiring a downward adjustment in the stock price.
Similarly, if the company's return on invested capital rises further above the current 18.27%, it would signal a level of capital efficiency that could justify a permanent re-rating of the company's historical valuation bands.
Final Research Read
In conclusion, the data presents a clear structural question: Merck & Co., Inc. is trading at cash, enterprise, and revenue multiples that sit near the top of their five-year ranges, while its five-year free cash flow CAGR is 15.69% and its ROIC is 18.27%. The sustainability of the current valuation depends on whether the company can accelerate its operational cash generation to match the premium priced into its historical multiples.
Research trail
Continue through the source pages behind this research note.
FAQ
Why does this bear case lead with P/OCF instead of the P/E ratio?
Because price-to-operating-cash-flow is the cleanest robust multiple. P/OCF is 1.1x its own five-year median, and unlike the trailing P/E of 36.24x it is not distorted by one-time charges, tax items, or non-cash accounting, so it gives a more reliable read on where the valuation actually sits versus its own history.
What commissioned this research note on MRK?
The divergence screener, not a request. It fired because P/OCF, EV/EBITDA, and P/S are clustered in the same band of their own five-year ranges — at the 76th percentile, 56th percentile, and 84th percentile respectively — while free cash flow has compounded at 15.69%.
What would prove this thesis wrong?
Growth re-accelerating from its recent pace, or the robust multiples falling back toward the middle of their own ranges. Either would mean the high multiple is being earned rather than stretched, and the premium is justified.
Claim ledger
Every numeric or dated claim in this note was resolved from precomputed TGMCharts data before publishing.
Research snapshot
Extractable thesis
Merck & Co., Inc. screened on an expensive-and-slowing divergence: P/OCF is 1.1x its own five-year median while free cash flow has compounded at 15.69%.
Data snapshot: 2026-06-26 / byline: TGMCharts Research / article status: published